- Record: found
- Abstract: found
- Article: not found
Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer.
G H Eltabbakh
1 ,
M S Piver ,
R E Hempling ,
F O Recio ,
S B Lele ,
D L Marchetti ,
T R Baker ,
L E Blumenson
Sep 1998
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The extreme drug resistance (EDR) assay has been correlated with failure of response to chemotherapy in greater than 99% of patients. The goal of this study is to correlate the results of the EDR assay to response to first-line paclitaxel/cisplatin among patients with epithelial ovarian cancer.